The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review ...

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

Phase 2 protocol submitted to HREC to evaluate tivoxavir marboxil (TXM) in a combined seasonal and bird flu study in the Southern Hemisphere Briefing documents submitted to FDA for a Type D meeting ...

Moderna in May voluntarily withdrew an application seeking approval of its combination shot targeting Covid-19 and influenza ... in the U.S., Hoge said Moderna is engaging closely with the FDA to ...

Some members of the scientific community have concern that they’re coming out of the COVID pandemic—exposure to the virus, ...

In fact, the CDC found that "maternal vaccination is the best proection against COVID-19 for pregnant women and infants less ...